News brief
On 2026-06-09, according to Xiniu Data, BioGeometry completed strategic financing, raising hundreds of millions of RMB. Investors were co-lead investor Shanghai Biotechnology Pharmaceutical Innovation Zhuanhua Fund, co-lead investor Guoke Investment, co-lead investor Dachencaizhi, co-lead investor Xinglian Capital, participating investor Gaorong Capital, participating investor Zhishu Capital. The company is a provider of generative AI protein design platforms.
Connected profiles
Explore
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2026年6月9日，据烯牛数据报道，百奥几何完成战略投资融资，金额数亿人民币。投资方为上海生物医药创新转化基金、国科投资、达晨财智、星连资本领投，高榕资本、指数资本跟投。该公司为生成式AI蛋白质设计平台提供商。